Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Calcineurin B Homologous Protein Isoform 2 Expression and Function in Low Serum Conditions in Non‐Small Cell Lung Cancer Cells

View through CrossRef
The Na + ‐H + exchanger isoform 1 (NHE1) is a key regulator of cell proliferation, migration and invasion in cells from a variety of solid tumors including non‐small cell lung cancer (NSCLC). The Calcineurin B Homologous Proteins (CHP1 and CHP2) appear to be essential cofactors to support NHE1 function. CHP2 expression is elevated in tumor cells. This elevated expression supports cell proliferation and tumor formation. To evaluate the role of CHP2 and NHE1 in NSCLC progression we use three cell lines. H1299 cells are a human NSCLC carcinoma cell line. H1299 CHP2KD is a modified H1299 cell line that lacks CHP2 expression and H1299 NHE1KD which lacks NHE1 expression. We have assessed the expression of CHP1, CHP2 and NHE1 in normal (10%) and low (0.5%) serum conditions through western blot analysis. While CHP1 and NHE1 expression does not change over 48 hours of low serum exposure in any cell line, CHP2 expression increases in both H1299 and H1299 NHE1KD cells. To investigate functionality, we evaluated in vitro tumor formation using a soft agar assay. H1299 cells formed a significant number of large tumors (> 500 µm diameter) in both high and low serum conditions. H1299 NHE1KD cells formed a very low number of tumors in 10% serum and no tumors in 0.5% serum. H1299 CHP2KD cells formed no large tumors under either serum condition. These data suggest a critical role for CHP2 expression in cell migration and tumor formation which allows NSCLC cells to maintain a more aggressive phenotype even in low serum conditions.
Title: Calcineurin B Homologous Protein Isoform 2 Expression and Function in Low Serum Conditions in Non‐Small Cell Lung Cancer Cells
Description:
The Na + ‐H + exchanger isoform 1 (NHE1) is a key regulator of cell proliferation, migration and invasion in cells from a variety of solid tumors including non‐small cell lung cancer (NSCLC).
The Calcineurin B Homologous Proteins (CHP1 and CHP2) appear to be essential cofactors to support NHE1 function.
CHP2 expression is elevated in tumor cells.
This elevated expression supports cell proliferation and tumor formation.
To evaluate the role of CHP2 and NHE1 in NSCLC progression we use three cell lines.
H1299 cells are a human NSCLC carcinoma cell line.
H1299 CHP2KD is a modified H1299 cell line that lacks CHP2 expression and H1299 NHE1KD which lacks NHE1 expression.
We have assessed the expression of CHP1, CHP2 and NHE1 in normal (10%) and low (0.
5%) serum conditions through western blot analysis.
While CHP1 and NHE1 expression does not change over 48 hours of low serum exposure in any cell line, CHP2 expression increases in both H1299 and H1299 NHE1KD cells.
To investigate functionality, we evaluated in vitro tumor formation using a soft agar assay.
H1299 cells formed a significant number of large tumors (> 500 µm diameter) in both high and low serum conditions.
H1299 NHE1KD cells formed a very low number of tumors in 10% serum and no tumors in 0.
5% serum.
H1299 CHP2KD cells formed no large tumors under either serum condition.
These data suggest a critical role for CHP2 expression in cell migration and tumor formation which allows NSCLC cells to maintain a more aggressive phenotype even in low serum conditions.

Related Results

Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma
The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma
Objectives: Esophageal squamous cell carcinoma is a highly prevalent cancer withpoor survival rate and prognosis. Increasing evidence suggests an important role for metabolic regul...

Back to Top